Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Medical Oncology
•
Thrombosis
•
Hematology
•
Hemostasis/Thrombosis
•
Primary Care
When do you consider indefinite anticoagulation in someone with first episode of distal/calf vein DVT?
Does your approach in this population differ compared to proximal DVTs?
Related Questions
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
Is there a role for DOAC use for patients with unprovoked PE, that have had recent sleeve gastrectomy with duodenal bypass?
How do you manage anticoagulation in a patient with DVT from likely malignant mechanical obstruction?
How would you manage superficial vein thrombosis that persists on imaging after treatment with full dose anticoagulation?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
What is your approach to symptomatic superficial thrombosis of the pelvic veins occurring in the immediate postpartum period?
How do you start and manage therapeutic SC heparin for acute thrombosis in pregnancy as the patient approaches delivery?
How long would you anticoagulate for PE developed after air travel in a woman on an estrogen-containing vaginal ring for contraception?